Browsing Tag
Anatomic Pathology
1 post
Is Fulgent Genetics rebuilding itself as a pathology-first diagnostics platform after losing a major customer?
Fulgent Genetics targets $350M 2026 revenue as pathology expansion reshapes its customer mix. Read how the strategy could stabilise growth.